Lewis H Titterton jr bought $8,820 of ANIX
director at Anixa Biosciences Inc. 3,000 shares at an average of $2.94, traded Jan 23, 2025, filed Jan 27, 2025.
Score components
- +15RoleDirector
- 0Trade size$9k at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +9.7%, 3m +0.7%, 6m +18.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-003733, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 23, 2025 | POpen-market purchase Common Stock | +2,000 | $2.91 | $5,820 | 932,334 | Jan 27, 2025 |
| Jan 24, 2025 | POpen-market purchase Common Stock | +1,000 | $3.00 | $3,000 | 933,334 | Jan 27, 2025 |
Related signals
Other insiders at Anixa Biosciences Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Anixa Biosciences Inc | Michael Catelani President, COO, & CFO | $16k 5,500 shares | +12% | |
| 30Weak | Anixa Biosciences Inc | Arnold M Baskies director | $14k 5,000 shares | +4% | |
| 45Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $19k 7,000 shares | +1% | |
| 46Moderate | Anixa Biosciences Inc | Lewis H Titterton jr director | $132k 49,036 shares | +5% | |
| 35Weak | Anixa Biosciences Inc | Lewis H Titterton jr director | $27k 10,000 shares | +1% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $8,250 3,000 shares | +0% | |
| 35Weak | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $14k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 51Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $17k 5,000 shares | +1% | |
| 47Moderate | Anixa Biosciences Inc | Amit Kumar Chief Executive Officer | $11k 3,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.